SCHEMBL519505

SCHEMBL519505

CC(=O)CCN(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL167380 0.97
Bromide SCHEMBL11714940 0.97
SCHEMBL805274 0.82
SCHEMBL11912053 0.81 ALDH1A1 (0.53)
SCHEMBL2036849 0.80 PAOX (0.67)
SCHEMBL12602742 0.79 ALDH1A1 (0.50)
SCHEMBL12248451 0.78 PAOX (0.70)
SCHEMBL280327 0.78 PAOX (0.70)
SCHEMBL25907273 0.78 PAOX (0.70)
SCHEMBL18154617 0.78 PAOX (0.70)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137516-A1 FLUORINATED MONOMERS, ANION EXCHANGE POLYMERS AND METHODS OF MAKING THE SAME THE CHEMOURS COMPANY FC, LLC (US) 2025-06-26 WO claimed
EP-3538515-A1 CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF Ramot at Tel-Aviv University Ltd. (IL) 2019-09-18 EP claimed
WO-2018087753-A1 CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) 2018-05-17 WO claimed
EP-3102579-A2 HETEROCYCLIC COMPOUNDS Cadila Healthcare Limited (IN) 2016-12-14 EP claimed
WO-2015132799-A2 NOVEL HETEROCYCLIC COMPOUNDS CADILA HEALTHCARE LIMITED (IN) 2015-09-11 WO claimed
CN-102969039-A Photosensitive conductive silver electrode slurry and preparation method thereof IRICO GROUP CORP 2013-03-13 CN claimed
US-4128728-A Production of 2,3,6-trimethylphenol BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DE) 1978-12-05 US claimed
JP-59130843-A None JP disclosed
EP-4735418-A1 LIPID COMPOUNDS FOR GENE DELIVERY AND USE THEREOF Li, Bowen (CA) 2026-05-06 EP disclosed
EP-4590676-A1 HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLINE VMAT2 INHIBITORS AND METHODS OF USE Neurocrine Biosciences, Inc. (US) 2025-07-30 EP disclosed
EP-4577549-A1 COMPOUNDS AND METHODS FOR MODULATING HER2 Iambic Therapeutics, Inc. (US) 2025-07-02 EP disclosed
WO-2025137516-A1 FLUORINATED MONOMERS, ANION EXCHANGE POLYMERS AND METHODS OF MAKING THE SAME THE CHEMOURS COMPANY FC, LLC (US) 2025-06-26 WO disclosed
CN-119907800-A Hexahydro-2H-pyrido [2,1-a ] isoquinoline VMAT2 inhibitors and methods of use thereof 纽罗克里生物科学有限公司 2025-04-29 CN disclosed
US-4066780-A Pyranoindole derivatives as antiulcer agents AYERST MCKENNA AND HARRISON LTD. (CA) 1978-01-03 US disclosed
US-4041169-A TREATING AND PREVENTING ULCERS AYERST MCKENNA AND HARRISON LTD. (CA) 1977-08-09 US disclosed
US-4035495-A HYPERTENSIVE AGENTS, CNS DEPRESSANT AYERST MCKENNA AND HARRISON LTD. (CA) 1977-07-12 US disclosed
US-4033977-A ANTIINFLAMMATORY, ANTIDEPRESSANT AMERICAN HOME PRODUCTS CORPORATION (US) 1977-07-05 US disclosed
US-4003913-A ANTIDEPRESSANTS, ANTIULCER AGENTS AYERST MCKENNA AND HARRISON LTD. (CA) 1977-01-18 US disclosed
US-3995052-A Indenopyran- and indenothiopyranalkylamines III in the treatment of depression AYERST MCKENNA AND HARRISON LTD. (CA) 1976-11-30 US disclosed
US-3956316-A PROGESTATIONAL AND SALT-RETAINING AGENTS HOFFMANN-LA ROCHE INC. (US) 1976-05-11 US disclosed